Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Preferred Stock Liabilities (2017 - 2021)

Historic Preferred Stock Liabilities for Cogent Biosciences (COGT) over the last 4 years, with Q3 2021 value amounting to $85.4 million.

  • Cogent Biosciences' Preferred Stock Liabilities fell 3821.98% to $85.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $85.4 million, marking a year-over-year decrease of 3821.98%. This contributed to the annual value of $110.9 million for FY2020, which is N/A changed from last year.
  • Per Cogent Biosciences' latest filing, its Preferred Stock Liabilities stood at $85.4 million for Q3 2021, which was down 3821.98% from $85.4 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Preferred Stock Liabilities registered a high of $138.2 million during Q3 2020, and its lowest value of $77.2 million during Q4 2017.
  • Moreover, its 4-year median value for Preferred Stock Liabilities was $85.4 million (2021), whereas its average is $95.6 million.
  • Over the last 5 years, Cogent Biosciences' Preferred Stock Liabilities had its largest YoY gain of 3821.98% in 2021, and its largest YoY loss of 3821.98% in 2021.
  • Cogent Biosciences' Preferred Stock Liabilities (Quarter) stood at $77.2 million in 2017, then grew by 0.02% to $77.2 million in 2018, then surged by 43.69% to $110.9 million in 2020, then dropped by 22.98% to $85.4 million in 2021.
  • Its last three reported values are $85.4 million in Q3 2021, $85.4 million for Q2 2021, and $94.7 million during Q1 2021.